BOUNDLESS BIO INC (BOLD) Stock Analyst Earnings Estimates
NASDAQ:BOLD - Nasdaq - US10170A1007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||
| EBITDA YoY % growth | -24.619M | -45.527M -84.93% | -53.839M -18.26% | N/A -39.22% | N/A -1.68% | N/A -5.30% | |
| EBIT YoY % growth | -25.301M | -46.469M -83.66% | -54.796M -17.92% | N/A -37.92% | N/A -11.20% | N/A -19.01% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A 49.45% | N/A -9.30% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.78 | -0.76 93.83% | -0.81 -4.98% | -0.87 -17.51% | -1.01 -30.49% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.479M -41.19% | -18.77M -11.18% | -19.876M -2.50% | -21.253M -13.56% | -23.823M -22.30% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.74 | -0.76 | 0.02 | 2.94% |
| Q2 2024 Q2Q % growth | -0.77 | -0.82 | 0.05 | 5.64% |
| Q1 2024 Q2Q % growth | -12.27 | -0.56 | -11.71 | -2,087.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -0.93% |
| Revenue | N/A | N/A | N/A | N/A |